Omega Therapeutics Inc (OMGA)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
CEO:
Mahesh Karande
Employees:
65
20 ACORN PARK DRIVE, CAMBRIDGE, MA 02140
(617) 949-4360

At Omega Therapeutics, our goal is to pioneer a new class of DNA-sequence-targeting, mRNA-encoded therapeutics to fundamentally transform human medicine in the service of patients. Our pioneering OMEGA Epigenomic Programming platform is designed to coopt natures universal operating system by harnessing the power of epigenetics, the mechani® for gene control and cell differentiation.

Data derived from most recent annual or quarterly report
Market Cap 192.665 Million Shares Outstanding47.808 Million Avg 30-day Volume 320.78 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-3.36
Price to Revenue724.695 Debt to Equity0.1096 EBITDA-72.24 Million
Price to Book Value1.6464 Operating Margin-17730.339799999998 Enterprise Value117.657 Million
Current Ratio15.231 EPS Growth0 Quick Ratio14.843
1 Yr BETA 2.0514 52-week High/Low 31.41 / 1.98 Profit Margin-18193.2039
Operating Cash Flow Growth0.0 Altman Z-Score3.9289 Free Cash Flow to Firm 0
Earnings Report2022-08-04

View recent insider trading info

Funds Holding OMGA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding OMGA BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BESHAR LUKE M

  • Director
18,118 2022-06-08 1

AFEYAN NOUBAR

  • Director
  • 10% Owner
18,118 2022-06-08 2

MENDLEIN JOHN

  • Director
18,118 2022-06-08 1

SZELA MARY T

  • Director
18,118 2022-06-08 1

YOUNG RICHARD A

  • Director
18,118 2022-06-08 1

LEVY ELLIOTT M.

  • Director
18,118 2022-06-08 1

REED JOSHUA CHIEF FINANCIAL OFFICER

  • Officer
320,000 2022-05-31 2

ZENG LING SEE REMARKS

  • Officer
270,000 2022-03-31 2

MCMANUS KEVIN CHIEF HUMAN RESOURCES OFFICER

  • Officer
125,000 2022-03-31 2

SAWHNEY ROGER CHIEF FINANCIAL OFFICER

  • Officer
60,000 2022-03-09 2

MCCAULEY THOMAS CHIEF SCIENTIFIC OFFICER

  • Officer
110,000 2022-03-09 1

KARANDE MAHESH PRESIDENT AND CEO

  • Officer
  • Director
340,000 2022-03-09 2

MOORE YAN CHIEF MEDICAL OFFICER

  • Officer
477,715 2022-01-31 2

BERRY DAVID A

  • Director
53,082 2021-08-03 1

FLAGSHIP PIONEERING INC.

FLAGSHIP PIONEERING FUND VI GENERAL PARTNER LLC

FLAGSHIP PIONEERING FUND VI, L.P.

FLAGSHIP PIONEERING SPECIAL OPPORTUNITIES FUND II, L.P.

FLAGSHIP PIONEERING SPECIAL OPPORTUNITIES FUND II GENERAL PARTNER LLC

NUTRITIONAL HEALTH LTP FUND, L.P.

NUTRITIONAL HEALTH LTP FUND GENERAL PARTNER LLC

FPN GENERAL PARTNER LLC

FPN, L.P.

AFEYAN NOUBAR

  • Director
  • 10% Owner
25,902,269 2021-08-03 2

FLAGSHIP PIONEERING INC.

FLAGSHIP VENTURES FUND V GENERAL PARTNER LLC

FLAGSHIP V VENTURELABS RX FUND, L.P.

FLAGSHIP VENTURES FUND V, L.P.

FLAGSHIP VENTURELABS V MANAGER LLC

FLAGSHIP VENTURELABS V LLC

  • 10% Owner
25,902,269 2021-08-03 1

INVUS PUBLIC EQUITIES, L.P.

ARTAL INTERNATIONAL S.C.A.

ARTAL INTERNATIONAL MANAGEMENT S.A.

ARTAL GROUP S.A.

WESTEND S.A.

WITTOUCK AMAURY

STICHTING ADMINISTRATIEKANTOOR WESTEND

ARTAL TREASURY LTD

INVUS PUBLIC EQUITIES ADVISORS, LLC

  • 10% Owner
2,273,530 2021-07-30 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SZELA MARY T - Director

2022-06-10 16:10:21 -0400 2022-06-08 A 18,118 a 18,118 direct

YOUNG RICHARD A - Director

2022-06-10 16:10:23 -0400 2022-06-08 A 18,118 a 18,118 direct

AFEYAN NOUBAR - Director - > 10% Owner

2022-06-10 16:10:26 -0400 2022-06-08 A 18,118 a 18,118 direct

BESHAR LUKE M - Director

2022-06-10 16:10:30 -0400 2022-06-08 A 18,118 a 18,118 direct

MENDLEIN JOHN - Director

2022-06-10 16:10:33 -0400 2022-06-08 A 18,118 a 18,118 direct

LEVY ELLIOTT M. - Director

2022-06-10 16:10:36 -0400 2022-06-08 A 18,118 a 18,118 direct

REED JOSHUA - Officer CHIEF FINANCIAL OFFICER

2022-06-02 18:51:29 -0400 2022-05-31 A 320,000 a 320,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
OMEGA THERAPEUTICS INC OMGA 2022-06-29 22:15:03 UTC -5.7549 7.3249 9000
OMEGA THERAPEUTICS INC OMGA 2022-06-29 21:45:05 UTC -5.7549 7.3249 9000
OMEGA THERAPEUTICS INC OMGA 2022-06-29 21:15:03 UTC -5.7549 7.3249 9000
OMEGA THERAPEUTICS INC OMGA 2022-06-29 20:45:03 UTC -5.7549 7.3249 9000
OMEGA THERAPEUTICS INC OMGA 2022-06-29 20:15:04 UTC -5.7549 7.3249 9000
OMEGA THERAPEUTICS INC OMGA 2022-06-29 19:45:03 UTC -5.7549 7.3249 9000
OMEGA THERAPEUTICS INC OMGA 2022-06-29 19:15:04 UTC -5.7549 7.3249 9000
OMEGA THERAPEUTICS INC OMGA 2022-06-29 18:45:03 UTC -5.6079 7.1779 9000
OMEGA THERAPEUTICS INC OMGA 2022-06-29 18:15:03 UTC -5.6079 7.1779 9000
OMEGA THERAPEUTICS INC OMGA 2022-06-29 17:45:03 UTC -5.6079 7.1779 10000
OMEGA THERAPEUTICS INC OMGA 2022-06-29 17:15:03 UTC -5.6079 7.1779 10000
OMEGA THERAPEUTICS INC OMGA 2022-06-29 16:45:03 UTC -5.5756 7.1456 10000
OMEGA THERAPEUTICS INC OMGA 2022-06-29 16:15:03 UTC -5.5756 7.1456 10000
OMEGA THERAPEUTICS INC OMGA 2022-06-29 15:45:03 UTC -5.5756 7.1456 10000
OMEGA THERAPEUTICS INC OMGA 2022-06-29 15:15:03 UTC -5.5756 7.1456 2000
OMEGA THERAPEUTICS INC OMGA 2022-06-29 14:45:03 UTC -5.5756 7.1456 700
OMEGA THERAPEUTICS INC OMGA 2022-06-29 14:15:03 UTC -5.5756 7.1456 2000
OMEGA THERAPEUTICS INC OMGA 2022-06-29 13:45:03 UTC -5.5756 7.1456 2000
OMEGA THERAPEUTICS INC OMGA 2022-06-29 13:15:03 UTC -5.5756 7.1456 2000
OMEGA THERAPEUTICS INC OMGA 2022-06-29 12:45:02 UTC -5.5756 7.1456 1000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund OMGA -100.0 shares, $-624.0 2022-03-31 N-PORT

Elevate your investments